title: Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.
abstract: The CA125 antigen, recognized by the OC125 antibody, is a tissue-specific circulating antigen expressed in ovarian cancer. The CA125 antigen is encoded by the MUC16 gene cloned by Yin and Lloyd. The full-length gene describes a complex tethered mucin protein present primarily in a variety of gynecologic tissues, especially neoplasms. OC125 and other related antibodies react with glycosylation-dependent antigens present exclusively in the cleaved portion of the molecule. These antibodies are not useful as screening tools, nor can they detect the proximal residual MUC16 protein fragment after cleavage. This has limited its diagnostic and therapeutic applications. Using synthetic peptides, we raised novel-specific antibodies to the carboxy-terminal portion of MUC16 retained by the cell proximal to the putative cleavage site. These antibodies were characterized using fluorescence-activated cell-sorting analysis, enzyme-linked immunoassay, Western blot analysis, and immunohistochemistry. Each of the selected monoclonal antibodies was reactive against recombinant GST-ΔMUC16 protein and the MUC16-transfected SKOV3 cell line. Three antibodies, 4H11, 9C9, and 4A5 antibodies showed high affinities by Western blot analysis and saturation-binding studies of transfected-SKOV3 cells and displayed antibody internalization. Immunohistochemical positivity with novel antibody 4H11 was similar to OC125 but with important differences, including diffuse positivity in lobular breast cancer and a small percentage of OC125-negative ovarian carcinomas that showed intense and diffuse 4H11. Development of such antibodies may be useful for the characterization of MUC16 biology and allow for future studies in targeted therapy and diagnostics.
authors.affiliation: Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
authors.forename: Thapi
authors.initials: T
authors.lastname: Dharma Rao
authors.forename: Kay J
authors.initials: KJ
authors.lastname: Park
authors.forename: Peter
authors.initials: P
authors.lastname: Smith-Jones
authors.forename: Alexia
authors.initials: A
authors.lastname: Iasonos
authors.forename: Irina
authors.initials: I
authors.lastname: Linkov
authors.forename: Robert A
authors.initials: RA
authors.lastname: Soslow
authors.forename: David R
authors.initials: DR
authors.lastname: Spriggs
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D000911:Antibodies, Monoclonal / Q000302:isolation & purification / Q000378:metabolism*; D001943:Breast Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D018394:CA-125 Antigen / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D045744:Cell Line, Tumor; D002469:Cell Separation; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D008168:Lung / Q000378:metabolism / Q000473:pathology; D008297:Male; D008565:Membrane Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D010053:Ovary / Q000378:metabolism / Q000473:pathology; D010179:Pancreas / Q000378:metabolism / Q000473:pathology; D011467:Prostate / Q000378:metabolism / Q000473:pathology; D019076:Transgenes / Q000235:genetics / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D018394:CA-125 Antigen; C451759:MUC16 protein, human; D008565:Membrane Proteins
references.citation: Int J Cancer. 2002 Apr 10;98(5):737-40
references.pmid: 11920644
references.citation: J Clin Invest. 1981 Nov;68(5):1331-7
references.pmid: 7028788
references.citation: Nat Med. 1998 Jul;4(7):844-7
references.pmid: 9662379
references.citation: Cancer Cell. 2004 Feb;5(2):163-75
references.pmid: 14998492
references.citation: Tumour Biol. 1993;14(5):310-8
references.pmid: 8235310
references.citation: Clin Cancer Res. 2004 Jun 1;10(11):3919-26
references.pmid: 15173101
references.citation: Tumour Biol. 2002 Sep-Oct;23(5):303-14
references.pmid: 12595747
references.citation: Cancer Biol Ther. 2003 Nov-Dec;2(6):702-6
references.pmid: 14688481
references.citation: J Biol Chem. 2001 Jul 20;276(29):27371-5
references.pmid: 11369781
references.citation: Br J Cancer. 1984 Jul;50(1):23-30
references.pmid: 6331484
references.citation: Tumour Biol. 1996;17(6):325-31
references.pmid: 8938947
references.citation: Tumour Biol. 1997;18(5):278-89
references.pmid: 9276028
references.citation: Tumour Biol. 2002 May-Jun;23(3):154-69
references.pmid: 12218296
references.citation: Mol Biol Cell. 2006 Jul;17(7):2931-41
references.pmid: 16624867
references.citation: Gynecol Oncol. 2010 Feb;116(2):240-5
references.pmid: 19879639
references.citation: Hum Pathol. 2002 Oct;33(10):968-74
references.pmid: 12395368
references.citation: Biochem Biophys Res Commun. 2004 Mar 5;315(2):471-6
references.pmid: 14766232
references.citation: Oncogene. 2006 Jan 5;25(1):20-31
references.pmid: 16158055
references.citation: J Biol Chem. 2009 Feb 6;284(6):3739-49
references.pmid: 19075018
references.citation: N Engl J Med. 1983 Oct 13;309(15):883-7
references.pmid: 6310399
references.citation: Br J Cancer. 2008 Aug 5;99(3):520-6
references.pmid: 18665193
references.citation: Gynecol Oncol. 2005 Nov;99(2):267-77
references.pmid: 16061277
references.citation: Int J Gynecol Pathol. 2008 Apr;27(2):161-74
references.pmid: 18317227
references.citation: Nat Rev Cancer. 2004 Jan;4(1):45-60
references.pmid: 14681689
references.citation: Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:274-81
references.pmid: 16343244
references.citation: Tumour Biol. 2001 Nov-Dec;22(6):348-66
references.pmid: 11786729
references.citation: Cancer Res. 2008 Nov 15;68(22):9231-8
references.pmid: 19010895
references.citation: Biochemistry. 1978 Oct 31;17(22):4807-17
references.pmid: 215191